-
NNMT promotes tubular senescence and fibrosis in chronic kidney disease
Chanvillard, L., Lantermans, H., Wall, C., Thevenet, J., Butter, L., Tauzin, L., Claessen, N., Christen, S., Karaz, S., Lassueur, S., Lizzo, G., Sanchez-Garcia, J. L., Métairon, S., Holzwarth, J. A., Ferro, V., Moco, S., van Bommel, E. J. M., van Baar, M. J. B., Hesp, A. C. & van Raalte, D. H. & 5 others, , 1 Jan 2025, In: bioRxiv. p. 2025.01.06.631437Research output: Contribution to journal › Article* › Academic
-
Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
van der Hoek, S., Koomen, J. V., van Bommel, E. J. M., Mosterd, C. M., Scholtes, R. A., Hesp, A. C., Stevens, J., van Raalte, D. H. & Heerspink, H. J. L., 1 May 2023, In: Journal of Personalized Medicine. 13, 5, 747.Research output: Contribution to journal › Article* › Academic › peer-review
-
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
Scholtes, R. A., Mosterd, C. M., Hesp, A. C., Smits, M. M., Heerspink, H. J. L. & van Raalte, D. H., Jan 2023, In: Diabetes, obesity & metabolism. 25, 1, p. 198-207 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
